ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC … – Markets Insider

Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC …Markets Insider“P‐PSMA‐101 is a CAR-T cell therapeutic that exhibits a persistently high percentage of stem cell memory T-cells and med… Continue reading

2017-11-08 Michael Zand NEWS

New gene therapy technique saves boy’s life by growing new skin – Engadget

Continue reading

2017-11-08 Michael Zand NEWS

CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update – Markets Insider

CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business UpdateMarkets Insider“CRISPR Therapeutics substantially completed the preclinical activities in the third quarter for CTX001, our lead program targeting two hemogl… Continue reading

2017-11-08 Michael Zand NEWS

Spark gene therapy for blindness could come at steep cost – BioPharma Dive


Engadget

New gene therapy technique saves boy’s life by growing new skin
Engadget
A young boy with a rare genetic skin disorder is alive and well two years after an experimental gene therapy technique was used to grow and replace nine square feet of his skin. The paper, just published in the journal Nature, describes how doctors in …
Gene Therapy Skin Grafts Save Boy With Rare DiseaseNBCNews.com
Gene Therapy Creates Replacement Skin to Save a Dying BoyNew York Times
Boy With Rare Disease Gets Brand New Skin With Gene TherapySnopes.com
The Times of Israel –Popular Science –Genetics Home Reference – NIH –Centro di Medicina Rigenerativa “Stefano Ferrari”
all 177 news articles »
Continue reading

2017-11-08 Michael Zand NEWS

CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update – GlobeNewswire (press release)

CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business UpdateGlobeNewswire (press release)ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing com… Continue reading

2017-11-08 Michael Zand NEWS

Groundbreaking Gene Therapy Saves Dying Boy of Rare Skin Disease, Could Cure Future “Butterfly Children” – Good News Network

Good News NetworkGroundbreaking Gene Therapy Saves Dying Boy of Rare Skin Disease, Could Cure Future “Butterfly Children”Good News NetworkA revolutionary treatment has been used to save the life of a young Syrian refugee who suffers from a rare and ter… Continue reading

2017-11-08 Michael Zand NEWS

Improving cancer immunotherapy by harnessing new technology – FierceBiotech

Spark gene therapy for blindness could come at steep cost
BioPharma Dive
Early next year, Spark Therapeutics Inc.’s gene therapy Luxturna could become the first such treatment for an inherited condition to win approval in the U.S., bringing with it new hope for patients with a rare form of childhood blindness. At the same …

Continue reading

2017-11-08 Michael Zand NEWS

Gene therapy inhibits multiple sclerosis in mouse models – The Ledger

Gene therapy inhibits multiple sclerosis in mouse modelsThe LedgerGAINESVILLE — Multiple sclerosis can be inhibited or reversed in mouse models using a novel gene therapy technique to suppress the immune response that induces the disease, University of… Continue reading

2017-11-08 Michael Zand NEWS
  • 1
  • …
  • 922
  • 923
  • 924
  • 925
  • 926
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FierceBiotech

Improving cancer immunotherapy by harnessing new technology
FierceBiotech
“We think we have developed a straightforward way to modify the really important immunotherapy drugs that work remarkably well in some patients but don’t work at all in others,” said lead author Jeffrey Hubbell, Ph.D., a professor of tissue engineering …